CA2498639A1 - Utilisation d'acide nicotinique (niacine) comme complement oral pour le traitement et la prevention de dysfonctions sexuelles chez les hommes et les femmes - Google Patents

Utilisation d'acide nicotinique (niacine) comme complement oral pour le traitement et la prevention de dysfonctions sexuelles chez les hommes et les femmes Download PDF

Info

Publication number
CA2498639A1
CA2498639A1 CA002498639A CA2498639A CA2498639A1 CA 2498639 A1 CA2498639 A1 CA 2498639A1 CA 002498639 A CA002498639 A CA 002498639A CA 2498639 A CA2498639 A CA 2498639A CA 2498639 A1 CA2498639 A1 CA 2498639A1
Authority
CA
Canada
Prior art keywords
niacin
flush
females
sexual dysfunction
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002498639A
Other languages
English (en)
Inventor
J.D. Globus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002498639A priority Critical patent/CA2498639A1/fr
Publication of CA2498639A1 publication Critical patent/CA2498639A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
CA002498639A 2005-03-02 2005-03-02 Utilisation d'acide nicotinique (niacine) comme complement oral pour le traitement et la prevention de dysfonctions sexuelles chez les hommes et les femmes Abandoned CA2498639A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002498639A CA2498639A1 (fr) 2005-03-02 2005-03-02 Utilisation d'acide nicotinique (niacine) comme complement oral pour le traitement et la prevention de dysfonctions sexuelles chez les hommes et les femmes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002498639A CA2498639A1 (fr) 2005-03-02 2005-03-02 Utilisation d'acide nicotinique (niacine) comme complement oral pour le traitement et la prevention de dysfonctions sexuelles chez les hommes et les femmes

Publications (1)

Publication Number Publication Date
CA2498639A1 true CA2498639A1 (fr) 2006-09-02

Family

ID=36938920

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002498639A Abandoned CA2498639A1 (fr) 2005-03-02 2005-03-02 Utilisation d'acide nicotinique (niacine) comme complement oral pour le traitement et la prevention de dysfonctions sexuelles chez les hommes et les femmes

Country Status (1)

Country Link
CA (1) CA2498639A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1935422A1 (fr) * 2006-12-20 2008-06-25 PEJO Iserlohn Heilmittel-und Diät-GmbH & Co.KG Composition pharmaceutique comprenant la nicotinamide ou l'acide nicotinique
EP2057905A1 (fr) * 2007-11-12 2009-05-13 TIMA Foundation Composition de modération des niveaux de triglycéride et de cholestérol
US8465413B2 (en) 2010-11-25 2013-06-18 Coloplast A/S Method of treating Peyronie's disease
US9456982B2 (en) 2014-05-18 2016-10-04 Be-Warm Llc Solid formulations of niacin to counteract cold extremities

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1935422A1 (fr) * 2006-12-20 2008-06-25 PEJO Iserlohn Heilmittel-und Diät-GmbH & Co.KG Composition pharmaceutique comprenant la nicotinamide ou l'acide nicotinique
WO2008074860A1 (fr) * 2006-12-20 2008-06-26 Pejo Iserlohn Heilmittel Und Diaet Gmbh & Co. Kg Composition pharmaceutique comprenant du nicotinamide ou de l'acide nicotinique
EP2057905A1 (fr) * 2007-11-12 2009-05-13 TIMA Foundation Composition de modération des niveaux de triglycéride et de cholestérol
WO2009062910A1 (fr) * 2007-11-12 2009-05-22 Tima Foundation Composition pour modérer les taux de triglycérides et de cholestérol
US8465413B2 (en) 2010-11-25 2013-06-18 Coloplast A/S Method of treating Peyronie's disease
US9456982B2 (en) 2014-05-18 2016-10-04 Be-Warm Llc Solid formulations of niacin to counteract cold extremities

Similar Documents

Publication Publication Date Title
Varanese et al. Treatment of advanced Parkinson's disease
TWI583390B (zh) 富含鞣花單寧之萃取物組成物
KR20030025902A (ko) 덱스트로메토르판 및 옥시다제 억제제의 환자의 마약 및항진정제의 중단을 위한 용도
JP5731094B2 (ja) アセチルコリンエステラーゼ阻害剤による微小血管系疾患の治療
CA2498639A1 (fr) Utilisation d'acide nicotinique (niacine) comme complement oral pour le traitement et la prevention de dysfonctions sexuelles chez les hommes et les femmes
Rajput An overview on dysmenorrhea
RU2480209C1 (ru) Способ лечения нарушений менструального цикла у девушек-подростков с ожирением
EP4021433A1 (fr) Traitement de symptômes induits par le cycle menstruel
Houghton et al. Parkinson's disease: medications
RU2445100C2 (ru) Консервативный способ комплексного лечения острых и хронических анальных трещин
Houghton et al. Medications
Biziere et al. Living with Parkinson's disease
Bakheit et al. Successful treatment of severe abulia with co-beneldopa
Billot 38 years in the life of a patient with a hepato-digestive disorder. Effects of homeopathic dilutions in space and time
CN109475587B (zh) 改善睡眠、社会交往、忧虑或担忧的草药方法
WO2015139056A1 (fr) Composition anti-addictive
Rajiah et al. Psychological impotence: Psychological erectile dysfunction and erectile dysfunction causes, diagnostic methods and management options
Stapelfeldt et al. Ayurveda for a type 1 diabetes patient with peripheral arterial occlusive disease (PAOD)
Axe et al. The Essential Oils Home Remedy Guide
Streeter et al. Treatment of Non-Motor Symptoms: Autonomic Dysfunction
Emmanuel of Neurogenic Bowel
Roller et al. Disease state management: Parkinson's disease
Hubble et al. Medications
TW200927095A (en) Treatment of CNS and pain disorders
Parcell Health Topics AF

Legal Events

Date Code Title Description
FZDE Dead